NCT00483600View on ClinicalTrials.gov

Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction

NAWithdrawnINTERVENTIONAL

0

Timeline

Start Date

August 31, 2007

Study Completion Date

August 31, 2008

Conditions

Kidney Diseases

Interventions

DRUG

fondaparinux

injections of 2.5mg every other day for 4 weeks

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Duke University

OTHER